Abstract: According to various exemplary embodiments, there may be provided an electronic device including a housing having a first side and an opposite second side, a display disposed between the first side and the second side, an ElectroMagnetic Resonance (EMR) sensor pad disposed between the display and the second side, a pen placing space disposed between the first side and the second side to accommodate an electronic pen, and a detecting member disposed in vicinity of the electronic pen for detecting the electronic pen when the electronic pen is fully inserted into the pen placing space.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present invention relates to a cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory T-cells as an active ingredient. By infusing mesenchymal stem cells and immunoregulatory T-cells, which are the cellular therapeutic agent of the present invention, into bone marrow transplant animals, rejection to the host is suppressed after the engraftment of the transplanted bone-marrow to thus obtain the effect of reducing graft-versus-host disease and immune disease. Moreover, the effect of such GVHD reduction is much greater than the one obtained when only mesenchymal stem cells are infused. Accordingly, the cell therapy composition of the present invention having the above-mentioned effects can be useful in the prevention or treatment of immune disease.

Abstract: A test apparatus for measuring the temperature of a reactor using a thermochromic pigment, and a method for controlling the test apparatus are disclosed, based on a technology for irradiating light of different wavelengths on a thermochromic pigment accommodated in a reactor and estimating temperature of the reactor using a difference between absorbance values corresponding to the light of the different wavelengths. The test apparatus includes at least one light emitter configured to irradiate light of different wavelengths onto a chamber included in the reactor, a light receiver configured to receive the light that propagates through the chamber, and a controller configured to measure absorbance values of the thermochromic pigment in correspondence to the different wavelengths of the light, to calculate a difference between the measured absorbance values, and to determine a temperature of the reactor in correspondence to the calculated difference between the absorbance values.

Abstract: A manufacturing method of a semiconductor device includes forming a hard mask layer on a semiconductor substrate using a hard mask composition. Hard mask patterns are formed by patterning the hard mask layer. Semiconductor patterns are formed by etching the semiconductor substrate using the hard mask patterns. The hard mask composition includes a plurality of first carbon nanotubes (CNTs) having a first length, a plurality of second CNTs having a second length, which is at least 3 times the first length, and a dispersing agent in which the first CNTs and the second CNTs are dispersed. The total mass of the first CNTs is 1 to 2.5 times the total mass of the second CNTs.

Abstract: A system and method for processing a touch input. The system includes a touch screen configured to detect a touch on a touch screen panel, an outputter configured to output at least one of a vibration and a sound, a press sensor configured to detect user's pressing the touch screen panel by more than a predetermined strength, and a controller configured to, when the touch is detected where a user interface icon is displayed, control the outputter to output at least one of the vibration and the sound corresponding to the user interface icon, and, when a press on the touch screen panel is detected within a predetermined time after the touch is detected, perform a job corresponding to the user interface icon of location where the touch is detected.

Abstract: A touch panel is provided including at least one first electrode pattern including a plurality of electrode lines arranged in a first direction; and at least one second electrode pattern including a plurality of second electrode lines arranged in a second direction to crossing the first direction; with each of the first and second electrode patterns including a center electrode line and two electrode lines positioned on a side of the center electrode line, with a first space separating the center electrode line from one of the two electrode lines, with a second space separating the one of the two electrode lines from the other of the two electrode lines, and with the first space being different from the second space.

Abstract: A method for growing a crystalline composition, the first crystalline composition may include gallium and nitrogen. The crystalline composition may have an infrared absorption peak at about 3175 cm?1, with an absorbance per unit thickness of greater than about 0.01 cm?1. In one embodiment, the composition may have an amount of oxygen present in a concentration of less than about 3×1018 per cubic centimeter, and may be free of two-dimensional planar boundary defects in a determined volume of the first crystalline composition.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present invention relates to a composition for treating or preventing bone diseases comprising halofuginone as an active ingredient and, more specifically, to a composition for treating or preventing bone diseases, comprising, as an active ingredient, halofuginone having an osteoclast differentiation inhibitory efficacy and an osteoblast differentiation stimulatory activity. The composition for treating or preventing bone diseases, comprising halofuginone as an active ingredient, according to the present invention, reduces the expression of Th17 cells and increases the expression of Treg cells, thereby representing an effect of inhibiting osteoclast differentiation and being capable of also effectively inhibiting bone resorption by osteoclasts. Furthermore, the composition of the present invention will be able to be usefully utilized as a use for the treatment or prevention of bone diseases by being able to promote the differentiation and activity of osteoblast.

Abstract: The present invention relates to a lighting lamp system and a power distributor used for the lighting lamp system. The lighting lamp system comprising: a plurality of lighting lamps; a main converter for converting external alternating-current power into direct-current power; a distributor provided to be isolated from the lighting lamps and supplying power for lighting to the plurality of lighting lamps by converting the direct-current power from the main converter; and a controller for controlling the operations of the lighting lamps by controlling the distributor.

Abstract: A method for growing a crystalline composition, the first crystalline composition may include gallium and nitrogen. The crystalline composition may have an infrared absorption peak at about 3175 cm?1, with an absorbance per unit thickness of greater than about 0.01 cm?1. In one embodiment, the composition may have an amount of oxygen present in a concentration of less than about 3×1018 per cubic centimeter, and may be free of two-dimensional planar boundary defects in a determined volume of the first crystalline composition.

Abstract: The present invention relates to TNFR2-IL21R fusion protein acting as a double-antagonist to TNF-alpha (?) and IL-21. The composition containing the double antagonist to TNF-? and Il-21 (TNFR2-IL21R fusion protein), known as major causes of autoimmune rheumatoid arthritis, one of autoimmune diseases, can reduce the secretion of inflammatory cytokine, increase the secretion of anti-inflammatory cytokine, and suppress the differentiation of osteoclasts better than single proteins such as TNFR2-Fc and IL21R-Fc. The TNFR2-IL21R fusion protein of the present invention has not only excellent treatment effect on arthritis in CIA mouse model not also excellent treatment effect on autoimmune rheumatoid arthritis by increasing the expression of Treg, the immune suppressive cells. Therefore, the TNFR2-IL21R fusion protein of the present invention can be effectively used as an active ingredient for the composition for the prevention and treatment of autoimmune disease.

Abstract: A touch pen is provided. The touch pen is configured such that an indication point, which is indicated on a touch panel when the touch pen slantingly contacts the touch panel, is corrected to a contact point of the touch pen.

Abstract: The furfural-resistant strain containing the furfural-resistant gene according to the present disclosure may be effectively grown in a furfural-containing medium. Accordingly, the problem that microorganism fermentation was difficult because toxic by-products such as furfural are contained in a hydrolysate derived from inedible lignocellulosic biomass may be solved. Further, according to the method for producing a strain of the present disclosure, the resistant gene may be selected from relatively small number of target genes. Thus, time, cost and the like for developing the resistant strain may be saved. Further, this method for identifying genes may be broadly applied to methods for identifying various unknown functional genes in addition to the furfural-resistant gene.

Abstract: A sealing glass composition for providing a glass seal in an electrochemical cell is presented. The sealing glass composition includes boron oxide, aluminum oxide, barium oxide, and zirconium oxide, and the glass composition is substantially free of silicon oxide and titanium oxide. The electrochemical cell incorporating the glass seal is also provided.

Abstract: An RFID tag includes a textile including a loop region and a dipole region defined adjacent to the loop region, a dipole portion disposed in the dipole region and on the textile to be configured to receive an electric wave from outside, a loop portion disposed in the loop region and over the dipole portion to be configured to be capacitive coupled to the dipole portion to form an antenna together, an RFID chip interposed between the dipole portion and the loop portion, the RFID including a driving circuit for receiving and transmitting an electric wave through the antenna and a protective layer disposed on the textile with covering the dipole portion to protect the dipole portion.

Abstract: A touch panel is provided including at least one first electrode pattern including a plurality of electrode lines arranged in a first direction; and at least one second electrode pattern including a plurality of second electrode lines arranged in a second direction to crossing the first direction; with each of the first and second electrode patterns including a center electrode line and two electrode lines positioned on a side of the center electrode line, with a first space separating the center electrode line from one of the two electrode lines, with a second space separating the one of the two electrode lines from the other of the two electrode lines, and with the first space being different from the second space.

Abstract: Provided is a system and method for processing a touch input. The system includes: a touch screen configured to detect a touch on a touch screen panel; an outputter configured to output at least one of a vibration and a sound; a press sensor configured to detect user's pressing the touch screen panel by more than a predetermined strength; and a controller configured to, when the touch is detected where a user interface icon is displayed, control the outputter to output at least one of the vibration and the sound corresponding to the user interface icon, and, when a press on the touch screen panel is detected within a predetermined time after the touch is detected, perform a job corresponding to the user interface icon of location where the touch is detected.